---
layout: default
title: Zero-Shot Large Language Model Agents for Fully Automated Radiotherapy Treatment Planning
---

# Zero-Shot Large Language Model Agents for Fully Automated Radiotherapy Treatment Planning

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2510.11754" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2510.11754v1</a>
  <a href="https://arxiv.org/pdf/2510.11754.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2510.11754v1" onclick="toggleFavorite(this, '2510.11754v1', 'Zero-Shot Large Language Model Agents for Fully Automated Radiotherapy Treatment Planning')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Dongrong Yang, Xin Wu, Yibo Xie, Xinyi Li, Qiuwen Wu, Jackie Wu, Yang Sheng

**åˆ†ç±»**: physics.med-ph, cs.AI, cs.RO

**å‘å¸ƒæ—¥æœŸ**: 2025-10-12

**å¤‡æ³¨**: Accepted for poster presentation at the NeurIPS 2025 Workshop on GenAI for Health: Potential, Trust, and Policy Compliance

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºåŸºäºé›¶æ ·æœ¬å¤§è¯­è¨€æ¨¡å‹çš„å…¨è‡ªåŠ¨æ”¾å°„æ²»ç–—è®¡åˆ’æ–¹æ³•ï¼Œæå‡è®¡åˆ’è´¨é‡ã€‚**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `æ”¾å°„æ²»ç–—è®¡åˆ’` `å¤§è¯­è¨€æ¨¡å‹` `é›¶æ ·æœ¬å­¦ä¹ ` `è‡ªåŠ¨åŒ–` `è°ƒå¼ºæ”¾å°„æ²»ç–—` `é€†å‘ä¼˜åŒ–` `å¤´é¢ˆç™Œ`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. æ‰‹åŠ¨æ”¾å°„æ²»ç–—è®¡åˆ’è€—æ—¶ä¸”ä¾èµ–ä¸“å®¶ç»éªŒï¼Œéš¾ä»¥æ»¡è¶³æ—¥ç›Šå¢é•¿çš„ç™Œç—‡æ²»ç–—éœ€æ±‚ã€‚
2. åˆ©ç”¨å¤§è¯­è¨€æ¨¡å‹Agentä¸æ²»ç–—è®¡åˆ’ç³»ç»Ÿäº¤äº’ï¼Œå®ç°é›¶æ ·æœ¬çš„è‡ªåŠ¨é€†å‘æ²»ç–—è®¡åˆ’ã€‚
3. å®éªŒè¡¨æ˜ï¼Œè¯¥æ–¹æ³•åœ¨å±åŠå™¨å®˜ä¿æŠ¤æ–¹é¢ä¸ä¸´åºŠè®¡åˆ’ç›¸å½“ï¼Œå¹¶åœ¨çƒ­ç‚¹æ§åˆ¶å’Œé€‚å½¢æ€§æ–¹é¢æœ‰æ‰€æå‡ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

æ”¾å°„æ²»ç–—è®¡åˆ’æ˜¯ä¸€ä¸ªè¿­ä»£ä¸”ä¾èµ–ä¸“å®¶ç»éªŒçš„è¿‡ç¨‹ï¼Œæ—¥ç›Šå¢é•¿çš„ç™Œç—‡ç—…ä¾‹ä½¿å¾—ä¾èµ–æ‰‹åŠ¨è®¡åˆ’å˜å¾—éš¾ä»¥ä¸ºç»§ï¼Œå› æ­¤è‡ªåŠ¨åŒ–è‡³å…³é‡è¦ã€‚æœ¬ç ”ç©¶æå‡ºäº†ä¸€ç§åˆ©ç”¨åŸºäºå¤§è¯­è¨€æ¨¡å‹ï¼ˆLLMï¼‰çš„Agentæ¥æŒ‡å¯¼è°ƒå¼ºæ”¾å°„æ²»ç–—ï¼ˆIMRTï¼‰é€†å‘è®¡åˆ’çš„æµç¨‹ã€‚è¯¥LLM Agentç›´æ¥ä¸ä¸´åºŠæ²»ç–—è®¡åˆ’ç³»ç»Ÿï¼ˆTPSï¼‰äº¤äº’ï¼Œè¿­ä»£åœ°æå–ä¸­é—´è®¡åˆ’çŠ¶æ€å¹¶æå‡ºæ–°çš„çº¦æŸå€¼æ¥æŒ‡å¯¼é€†å‘ä¼˜åŒ–ã€‚Agentçš„å†³ç­–è¿‡ç¨‹åŸºäºå½“å‰çš„è§‚å¯Ÿå’Œä¹‹å‰çš„ä¼˜åŒ–å°è¯•åŠè¯„ä¼°ï¼Œä»è€Œå®ç°åŠ¨æ€çš„ç­–ç•¥æ”¹è¿›ã€‚è¯¥è®¡åˆ’è¿‡ç¨‹åœ¨é›¶æ ·æœ¬æ¨ç†è®¾ç½®ä¸­è¿›è¡Œï¼ŒLLMåœ¨æ²¡æœ‰äº‹å…ˆæ¥è§¦æ‰‹åŠ¨ç”Ÿæˆçš„æ²»ç–—è®¡åˆ’çš„æƒ…å†µä¸‹è¿è¡Œï¼Œå¹¶ä¸”æ²¡æœ‰ç»è¿‡ä»»ä½•å¾®è°ƒæˆ–ç‰¹å®šäºä»»åŠ¡çš„è®­ç»ƒã€‚åœ¨20ä¸ªå¤´é¢ˆç™Œç—…ä¾‹ä¸­ï¼ŒLLMç”Ÿæˆçš„è®¡åˆ’ä¸ä¸´åºŠæ‰‹åŠ¨è®¡åˆ’è¿›è¡Œäº†è¯„ä¼°ï¼Œåˆ†æå¹¶æŠ¥å‘Šäº†å…³é”®çš„å‰‚é‡å­¦ç»ˆç‚¹ã€‚LLMç”Ÿæˆçš„è®¡åˆ’åœ¨å®ç°ä¸ä¸´åºŠè®¡åˆ’ç›¸å½“çš„å±åŠå™¨å®˜ï¼ˆOARï¼‰ä¿æŠ¤çš„åŒæ—¶ï¼Œè¡¨ç°å‡ºæ”¹è¿›çš„çƒ­ç‚¹æ§åˆ¶ï¼ˆDmaxï¼š106.5ï¼… vs. 108.8ï¼…ï¼‰å’Œä¼˜å¼‚çš„é€‚å½¢æ€§ï¼ˆboost PTVçš„é€‚å½¢æŒ‡æ•°ï¼š1.18 vs. 1.39ï¼›primary PTVçš„é€‚å½¢æŒ‡æ•°ï¼š1.82 vs. 1.88ï¼‰ã€‚è¿™é¡¹ç ”ç©¶è¯æ˜äº†åœ¨å•†ä¸šTPSä¸­ï¼Œé›¶æ ·æœ¬ã€LLMé©±åŠ¨çš„è‡ªåŠ¨åŒ–IMRTæ²»ç–—è®¡åˆ’å·¥ä½œæµç¨‹çš„å¯è¡Œæ€§ã€‚æ‰€æå‡ºçš„æ–¹æ³•æä¾›äº†ä¸€ç§é€šç”¨ä¸”ä¸´åºŠä¸Šé€‚ç”¨çš„è§£å†³æ–¹æ¡ˆï¼Œå¯ä»¥å‡å°‘è®¡åˆ’çš„å˜å¼‚æ€§ï¼Œå¹¶æ”¯æŒæ›´å¹¿æ³›åœ°é‡‡ç”¨åŸºäºAIçš„è®¡åˆ’ç­–ç•¥ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæ”¾å°„æ²»ç–—è®¡åˆ’çš„é€†å‘ä¼˜åŒ–æ˜¯ä¸€ä¸ªå¤æ‚ä¸”è¿­ä»£çš„è¿‡ç¨‹ï¼Œéœ€è¦æ”¾å°„è‚¿ç˜¤å­¦å®¶å’Œç‰©ç†å¸ˆçš„ä¸“ä¸šçŸ¥è¯†ã€‚æ‰‹åŠ¨è®¡åˆ’è€—æ—¶ä¸”å®¹æ˜“å‡ºç°äººä¸ºè¯¯å·®ï¼Œä¸åŒè®¡åˆ’è€…ä¹‹é—´ä¹Ÿå­˜åœ¨å·®å¼‚ã€‚ç°æœ‰çš„è‡ªåŠ¨åŒ–æ–¹æ³•é€šå¸¸éœ€è¦å¤§é‡æ‰‹åŠ¨è®¡åˆ’æ•°æ®è¿›è¡Œè®­ç»ƒï¼Œæ³›åŒ–èƒ½åŠ›æœ‰é™ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šåˆ©ç”¨å¤§è¯­è¨€æ¨¡å‹ï¼ˆLLMï¼‰çš„å¼ºå¤§æ¨ç†èƒ½åŠ›ï¼Œå°†å…¶ä½œä¸ºä¸€ä¸ªæ™ºèƒ½Agentï¼Œç›´æ¥ä¸ä¸´åºŠæ²»ç–—è®¡åˆ’ç³»ç»Ÿï¼ˆTPSï¼‰äº¤äº’ã€‚Agenté€šè¿‡è§‚å¯Ÿå½“å‰çš„è®¡åˆ’çŠ¶æ€ï¼Œç»“åˆä¹‹å‰çš„ä¼˜åŒ–å°è¯•å’Œè¯„ä¼°ç»“æœï¼ŒåŠ¨æ€åœ°è°ƒæ•´ä¼˜åŒ–ç­–ç•¥ï¼Œä»è€Œå®ç°è‡ªåŠ¨åŒ–çš„é€†å‘è®¡åˆ’ã€‚è¿™ç§æ–¹æ³•æ— éœ€é¢„å…ˆè®­ç»ƒæˆ–å¾®è°ƒï¼Œå…·æœ‰è‰¯å¥½çš„æ³›åŒ–èƒ½åŠ›ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šæ•´ä½“æµç¨‹åŒ…æ‹¬ä»¥ä¸‹å‡ ä¸ªä¸»è¦æ­¥éª¤ï¼š1) LLM Agentåˆå§‹åŒ–ï¼Œè®¾å®šä¼˜åŒ–ç›®æ ‡å’Œçº¦æŸæ¡ä»¶ï¼›2) Agentä¸TPSäº¤äº’ï¼Œæå–å½“å‰è®¡åˆ’çŠ¶æ€ï¼ˆå¦‚å‰‚é‡åˆ†å¸ƒã€DVHç­‰ï¼‰ï¼›3) AgentåŸºäºå½“å‰çŠ¶æ€å’Œå†å²ç»éªŒï¼Œæå‡ºæ–°çš„çº¦æŸå€¼ï¼ŒæŒ‡å¯¼TPSè¿›è¡Œé€†å‘ä¼˜åŒ–ï¼›4) TPSæ ¹æ®Agentæå‡ºçš„çº¦æŸå€¼è¿›è¡Œä¼˜åŒ–ï¼Œç”Ÿæˆæ–°çš„è®¡åˆ’ï¼›5) Agentè¯„ä¼°æ–°è®¡åˆ’çš„è´¨é‡ï¼Œå¹¶æ›´æ–°ä¼˜åŒ–ç­–ç•¥ï¼›6) é‡å¤æ­¥éª¤2-5ï¼Œç›´åˆ°æ»¡è¶³ä¼˜åŒ–ç›®æ ‡æˆ–è¾¾åˆ°æœ€å¤§è¿­ä»£æ¬¡æ•°ã€‚

**å…³é”®åˆ›æ–°**ï¼šè¯¥æ–¹æ³•çš„æ ¸å¿ƒåˆ›æ–°åœ¨äºåˆ©ç”¨é›¶æ ·æœ¬å­¦ä¹ çš„å¤§è¯­è¨€æ¨¡å‹Agentï¼Œç›´æ¥ä¸ä¸´åºŠTPSäº¤äº’ï¼Œå®ç°å…¨è‡ªåŠ¨çš„æ”¾å°„æ²»ç–—è®¡åˆ’ã€‚ä¸ä¼ ç»Ÿçš„ç›‘ç£å­¦ä¹ æ–¹æ³•ç›¸æ¯”ï¼Œè¯¥æ–¹æ³•æ— éœ€å¤§é‡æ‰‹åŠ¨è®¡åˆ’æ•°æ®è¿›è¡Œè®­ç»ƒï¼Œå…·æœ‰æ›´å¥½çš„æ³›åŒ–èƒ½åŠ›å’Œé€‚åº”æ€§ã€‚æ­¤å¤–ï¼ŒAgentçš„å†³ç­–è¿‡ç¨‹æ˜¯åŠ¨æ€çš„ï¼Œå¯ä»¥æ ¹æ®å½“å‰çš„è®¡åˆ’çŠ¶æ€å’Œå†å²ç»éªŒè¿›è¡Œè°ƒæ•´ï¼Œä»è€Œå®ç°æ›´ä¼˜çš„ä¼˜åŒ–ç»“æœã€‚

**å…³é”®è®¾è®¡**ï¼šAgentçš„è®¾è®¡åŒ…æ‹¬ä»¥ä¸‹å‡ ä¸ªå…³é”®æ–¹é¢ï¼š1) çŠ¶æ€è¡¨ç¤ºï¼šAgentéœ€è¦èƒ½å¤Ÿå‡†ç¡®åœ°ç†è§£å½“å‰çš„è®¡åˆ’çŠ¶æ€ï¼ŒåŒ…æ‹¬å‰‚é‡åˆ†å¸ƒã€DVHã€å±åŠå™¨å®˜çš„å‰‚é‡ç­‰ä¿¡æ¯ã€‚2) åŠ¨ä½œç©ºé—´ï¼šAgentéœ€è¦èƒ½å¤Ÿæå‡ºæœ‰æ•ˆçš„çº¦æŸå€¼ï¼ŒæŒ‡å¯¼TPSè¿›è¡Œé€†å‘ä¼˜åŒ–ã€‚3) å¥–åŠ±å‡½æ•°ï¼šAgentéœ€è¦èƒ½å¤Ÿè¯„ä¼°è®¡åˆ’çš„è´¨é‡ï¼Œå¹¶æ ¹æ®è¯„ä¼°ç»“æœè°ƒæ•´ä¼˜åŒ–ç­–ç•¥ã€‚4) æ¢ç´¢ç­–ç•¥ï¼šAgentéœ€è¦åœ¨æ¢ç´¢æ–°çš„ä¼˜åŒ–ç­–ç•¥å’Œåˆ©ç”¨å·²æœ‰çš„ç»éªŒä¹‹é—´è¿›è¡Œå¹³è¡¡ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

åœ¨20ä¸ªå¤´é¢ˆç™Œç—…ä¾‹çš„å®éªŒä¸­ï¼ŒLLMç”Ÿæˆçš„è®¡åˆ’åœ¨å±åŠå™¨å®˜ä¿æŠ¤æ–¹é¢ä¸ä¸´åºŠæ‰‹åŠ¨è®¡åˆ’ç›¸å½“ï¼Œå¹¶ä¸”åœ¨çƒ­ç‚¹æ§åˆ¶ï¼ˆDmaxï¼š106.5ï¼… vs. 108.8ï¼…ï¼‰å’Œé€‚å½¢æ€§ï¼ˆboost PTVçš„é€‚å½¢æŒ‡æ•°ï¼š1.18 vs. 1.39ï¼›primary PTVçš„é€‚å½¢æŒ‡æ•°ï¼š1.82 vs. 1.88ï¼‰æ–¹é¢æœ‰æ‰€æå‡ã€‚è¿™äº›ç»“æœè¡¨æ˜ï¼Œè¯¥æ–¹æ³•å…·æœ‰è‰¯å¥½çš„ä¸´åºŠåº”ç”¨æ½œåŠ›ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶æˆæœå¯åº”ç”¨äºä¸´åºŠæ”¾å°„æ²»ç–—è®¡åˆ’çš„è‡ªåŠ¨åŒ–ï¼Œå‡å°‘è®¡åˆ’æ—¶é—´å’Œäººä¸ºè¯¯å·®ï¼Œæé«˜è®¡åˆ’è´¨é‡å’Œä¸€è‡´æ€§ã€‚è¯¥æ–¹æ³•å…·æœ‰è‰¯å¥½çš„æ³›åŒ–èƒ½åŠ›ï¼Œå¯ä»¥åº”ç”¨äºä¸åŒç±»å‹çš„ç™Œç—‡å’Œæ²»ç–—æŠ€æœ¯ã€‚æ­¤å¤–ï¼Œè¯¥æ–¹æ³•è¿˜å¯ä»¥ä½œä¸ºè¾…åŠ©å·¥å…·ï¼Œå¸®åŠ©æ”¾å°„è‚¿ç˜¤å­¦å®¶å’Œç‰©ç†å¸ˆæ›´å¥½åœ°ç†è§£å’Œä¼˜åŒ–æ²»ç–—è®¡åˆ’ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Radiation therapy treatment planning is an iterative, expertise-dependent process, and the growing burden of cancer cases has made reliance on manual planning increasingly unsustainable, underscoring the need for automation. In this study, we propose a workflow that leverages a large language model (LLM)-based agent to navigate inverse treatment planning for intensity-modulated radiation therapy (IMRT). The LLM agent was implemented to directly interact with a clinical treatment planning system (TPS) to iteratively extract intermediate plan states and propose new constraint values to guide inverse optimization. The agent's decision-making process is informed by current observations and previous optimization attempts and evaluations, allowing for dynamic strategy refinement. The planning process was performed in a zero-shot inference setting, where the LLM operated without prior exposure to manually generated treatment plans and was utilized without any fine-tuning or task-specific training. The LLM-generated plans were evaluated on twenty head-and-neck cancer cases against clinical manual plans, with key dosimetric endpoints analyzed and reported. The LLM-generated plans achieved comparable organ-at-risk (OAR) sparing relative to clinical plans while demonstrating improved hot spot control (Dmax: 106.5% vs. 108.8%) and superior conformity (conformity index: 1.18 vs. 1.39 for boost PTV; 1.82 vs. 1.88 for primary PTV). This study demonstrates the feasibility of a zero-shot, LLM-driven workflow for automated IMRT treatment planning in a commercial TPS. The proposed approach provides a generalizable and clinically applicable solution that could reduce planning variability and support broader adoption of AI-based planning strategies.

